Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04601272 · ClinicalTrials.gov registry record
Evaluating the Shared Decision Making Process Scale in Cancer Screening Decisions
A clinical trial, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- 240
- Enrollment target
NCT04601272: Completed study, sponsored by Massachusetts General Hospital.
NCT04601272 is a clinical trial that has completed, run by Massachusetts General Hospital. The registered enrollment target is 240 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04601272 has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- 240 participants
- Enrollment target
Study Summary
The purpose of this retrospective observational study is to evaluate the performance of the Shared Decision Making Process scale in a sample of patients who have received a decision aid about the decision to screen or not screen for breast cancer, colon cancer, prostate cancer, or lung cancer.
Interventions
- BEHAVIORAL Decision aid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2020-09-29 |
| Est. Completion | 2021-06-24 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04601272
The ClinicalTrials.gov registry entry for NCT04601272 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 240 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Decision aid is the first listed.
NCT04601272 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04601272 about?
NCT04601272 is a clinical study titled "Evaluating the Shared Decision Making Process Scale in Cancer Screening Decisions". The purpose of this retrospective observational study is to evaluate the performance of the Shared Decision Making Process scale in a sample of patients who have received a decision aid about the decision to screen or not screen for breast cancer, colon cancer, prostate cancer, or lung cancer.
What is the current status of trial NCT04601272?
This trial is currently completed. The enrollment target is 240 participants. The study started on 2020-09-29. Estimated completion is 2021-06-24.
What interventions are being tested in trial NCT04601272?
The interventions under investigation include: Decision aid (BEHAVIORAL).
Who is sponsoring clinical trial NCT04601272?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.